Navigation Links
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Date:9/2/2008

IBIS-2 (Integrated Biomarker and Imaging Study) Results Demonstrate

Benefits of VH(R) IVUS in Drug Development

SAN DIEGO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) [ESC Booth # A2-D403], a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced today the use of its VH(R) IVUS (Virtual Histology IVUS) in GlaxoSmithKline's IBIS-2 trial (Integrated Biomarker and Imaging Study). In the study, Volcano's VH(R) IVUS technology demonstrated and quantified compositional changes in atherosclerotic plaque that occurred over time. In IBIS-2, VH(R) IVUS showed compositional changes in the placebo group that suggest continued progression of necrotic core despite standard of care therapy. Use of the novel Lp-PLA2 inhibitor, darapladib, plus standard of care therapy prevented this progression. VH(R) IVUS is a catheter-based technology that creates colorized tissue maps of plaque composition in real-time.

Despite remarkable advances in diagnosis and therapy, atherosclerotic cardiovascular disease (CVD) is the number one killer of men and women in the Western world. Principal manifestations of atherosclerotic cardiovascular disease are heart disease and stroke. Atherosclerosis is the underlying mechanism for coronary artery disease, ischemic strokes, and peripheral vascular disease. Although a number of factors contribute to CVD, elevated plasma levels of Lp-PLA2 (lipoprotein-associated phospholipase A2) are associated with an increased risk.

"The results of IBIS-2 indicated that many coronary vessels with mild angiographic disease have large atherosclerotic plaques, which can be identified by VH(R) IVUS. The ability to character
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
5. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
6. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
7. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
8. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
9. Modigene Platform Validated in Independent Phase III Trial of CTP Technology
10. Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology
11. GeoVax Reports Progress on Its AIDS Vaccine Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; ... diagnostic and other specialty veterinary products , today reported financial ... Second Quarter 2015 Highlights with Prior Year Comparison: ... $1.829 million, from $917 thousand. , Blood Analyzer and ... , Core Companion Animal revenue was up 19% to ...
(Date:7/29/2015)... July 27, 2015 Research and Markets ... the "Global Neurostimulation Devices Market 2015" ... forecast the global neurostimulation devices market to grow ... 2014-2019. The report, Global Neurostimulation Devices ... in-depth market analysis with inputs from industry experts. ...
(Date:7/29/2015)... -- At the 2015 AACC Annual Meeting & ... a first-of-its-kind smartphone test for chlamydia can detect ... the prevalence of this sexually transmitted disease (STD) ... Most people with chlamydia are not aware ... symptoms, but if left untreated, this STD can ...
Breaking Medicine Technology:Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8Global Neurostimulation Devices Market 2015-2019 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 3
... 15, 2011 Cordis Corporation, a worldwide leader in ... announced it will no longer pursue the development of ... on other cardiovascular therapies where significant patient need exists. ... and CYPHER SELECT® Plus Sirolimus-Eluting Coronary Stents by the ...
... Mass. and TORONTO, June 15, 2011 Generex Biotechnology ... Jos van der Woert has been appointed to act ... Express, Inc., following its spinout. From 2003 ... with Schering-Plough Corporation, concluding his tenure there as General ...
Cached Medicine Technology:Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent 2Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent 3Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent 4Generex Announces Appointment of CEO for Post-Spinout Antigen Express 2Generex Announces Appointment of CEO for Post-Spinout Antigen Express 3Generex Announces Appointment of CEO for Post-Spinout Antigen Express 4
(Date:7/29/2015)... Boston, MA (PRWEB) , ... July 29, 2015 ... ... nonconforming experience widespread discrimination and health inequities. Since 2012, Massachusetts law has provided ... public education, and business. However, the law does not protect against discrimination based ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Potomac Pilates, ... rebrand, changing its name to Rock the Reformer ® by Potomac Pilates. On ... http://www.RockTheReformer.com . Rock the Reformer ® by Potomac Pilates will continue to offer ...
(Date:7/29/2015)... ... July 29, 2015 , ... More than 28,000 ... providers of children living with autism will converge upon Penn State to share ... , The National Autism Conference will be held Aug. 3-6 at the Penn ...
(Date:7/29/2015)... MOUNT LAUREL, NJ (PRWEB) , ... July 29, ... ... Manager Certification’s (the Commission) CCM® credential for a five-year period, expiring November 30, ... of its CCM credential by submitting an application demonstrating the program’s compliance with ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami ... or alcohol addiction and mental health disorders. Acu-detox may begin taking off in the ... from drug and alcohol addiction. Although acupuncture is not a new practice, it is ...
Breaking Medicine News(10 mins):Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3
... ... ... ... ...
... Mild cognitive impairment (MCI) is often considered an ... genetic risk factors predisposing to MCI is critical for ... early treatment. In a groundbreaking study published in the ... Disease investigators successfully used artificial neural networks (ANNs) ...
... seasonal form of the H1N1 influenza virus is any indication, ... the pandemic H1N1 flu virus will become resistant to Tamiflu, ... at Ohio State University have traced the evolutionary history of ... the 1918 pandemic. It is one of three seasonal influenza ...
... have designed a urine test that can simultaneously measure ... marker of garlic consumption in humans. In a ... garlic people consumed, the lower the levels of the ... about body processes associated with nitrogen-containing compounds, scientists say. ...
... ... AV® Preeminent™ 5.0 out of 5 Martindale-Hubbell Peer Review Rating. , ... (PRWEB) March 1, 2010 -- ... complex litigation, recently announced that President and Senior Shareholder Leland Eugene “Gene” Backus had ...
... ... wirelessly stay in touch with its sci-tech news. Starting now, readers can read PhysOrg stories ... player, and read stories on the Amazon Kindle. , ... (PRWEB) March 1, 2010 -- As a leading source of science ...
Cached Medicine News:Health News:TherapEase Cuisine Provides Online Nutritional Services at Aurora Health Care 2Health News:TherapEase Cuisine Provides Online Nutritional Services at Aurora Health Care 3Health News:TherapEase Cuisine Provides Online Nutritional Services at Aurora Health Care 4Health News:TherapEase Cuisine Provides Online Nutritional Services at Aurora Health Care 5Health News:Predisposing factors for conversion of mild cognitive impairment to AD identified 2Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 2Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 3Health News:Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu 4Health News:New testing method hints at garlic's cancer-fighting potential 2Health News:New testing method hints at garlic's cancer-fighting potential 3Health News:Backus Receives Top Martindale Hubbell Rating 2Health News:Stay in Touch with PhysOrg Science News While on the Go - iPhone Apps, Amazon Kindle, Podcasts 2Health News:Stay in Touch with PhysOrg Science News While on the Go - iPhone Apps, Amazon Kindle, Podcasts 3Health News:Stay in Touch with PhysOrg Science News While on the Go - iPhone Apps, Amazon Kindle, Podcasts 4
... Ultra is a fully adjustable, air-displacement pipette ... is the latest member of the Pipetman ... robustness, accuracy, and precision. We also added ... from our customers. Eight models cover the ...
Research Series 2100 Adjustable-volume Pipette, 20-200 l, single-channel with adjustable-volume setting...
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
Medicine Products: